Envista Holdings (NVST) Retained Earnings (2017 - 2026)
Envista Holdings (NVST) recorded quarterly Retained Earnings of -$143.1 million in Q2 2026, down 26.41% quarter-over-quarter from -$113.2 million in Q4 2025, and up 47.6% on a YoY basis from -$97.0 million in Q2 2025.
Envista Holdings (NVST) Retained Earnings (2017 - 2026) Analysis & Trends
Envista Holdings' Retained Earnings history runs 10 years deep, the most recent figure standing at -$143.1 million for Q2 2026.
- In Q2 2026, Retained Earnings rose 47.6% year-over-year to -$143.1 million; the TTM figure through Apr 2026 stood at -$143.1 million (up 47.6% YoY), while the FY2025 annual figure was -$113.2 million, up 69.5% from the prior year.
- Retained Earnings was -$143.1 million for Q2 2026 at Envista Holdings, down from -$113.2 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $848.6 million in Q3 2023 to a low of -$496.8 million in Q2 2024.
- Historically, Retained Earnings has averaged -$69.4 million across 5 years, with a median of -$217.2 million in 2023.
- The sharpest annual moves came in 2022 and 2023: Retained Earnings plunged 156.36% in 2022, then soared 484.14% in 2023.
- A 5-year view of Retained Earnings shows it stood at -$225.1 million in 2022, then rose by 3.51% to -$217.2 million in 2023, then slumped by 70.86% to -$371.1 million in 2024, then surged by 69.5% to -$113.2 million in 2025, then fell by 26.41% to -$143.1 million in 2026.
- The last three Retained Earnings figures came in at -$143.1 million (Q2 2026), -$113.2 million (Q4 2025), and -$113.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 6.40 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 17.39 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 122.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 6.96 Bn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 4.48 Bn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -670.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 7.70 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 70.09 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 13.69 Bn |
| 10 | Envista Holdings | 4.06 Bn | 2.98 Bn | 390.10 Mn | -143.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -143.10 Mn |
| Dec 31, 2025 | -113.20 Mn |
| Sep 26, 2025 | -113.10 Mn |
| Jun 27, 2025 | -123.50 Mn |
| Mar 28, 2025 | -273.10 Mn |
| Dec 31, 2024 | -371.10 Mn |
| Sep 27, 2024 | -223.60 Mn |
| Jun 28, 2024 | -496.80 Mn |
| Mar 29, 2024 | -283.60 Mn |
| Dec 31, 2023 | -217.20 Mn |
| Sep 29, 2023 | 848.60 Mn |
| Jun 30, 2023 | -236.90 Mn |
| Mar 31, 2023 | 775.20 Mn |
| Dec 31, 2022 | -225.10 Mn |
| Sep 30, 2022 | -391.20 Mn |
| Jul 1, 2022 | 610.30 Mn |
| Apr 1, 2022 | -201.80 Mn |
| Dec 31, 2021 | 466.90 Mn |
| Oct 1, 2021 | -152.60 Mn |
| Jul 2, 2021 | 288.20 Mn |